If you would like to learn more about future focusIR related events and roundtables, please submit your details here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksGenus Regulatory News (GNS)

Share Price Information for Genus (GNS)

Share Price is delayed by 15 minutes
Get Live Data
2,248.00    -42.00 (-1.83%)
Bid:
2,240.00
Ask:
2,256.00
Spread: 16.00 (0.714%)
Market Cap: £1.49b
GNS Live PriceLast checked at - London Stock Exchange

Intraday Genus Share Chart

Director/PDMR Shareholding

20 Sep 2011 15:07

RNS Number : 5938O
Genus PLC
20 September 2011
 

20 September 2011

 

Genus plc

 

('Genus' or 'the Company')

 

Director/PDMR Shareholding

 

 

Genus announces that of 117,359 ordinary shares of 10 pence each in the Company ("Ordinary Shares") which vested today in favour of Richard Wood, Chief Executive, under the Genus 2004 Performance Share Plan (the "Plan"), 117,359 Ordinary Shares were today sold on behalf of Richard Wood at a price of 1,000 pence per Ordinary Share.

 

Richard Wood's direct shareholding in the Company stands at 45,856 Ordinary Shares which represents 0.08% of the issued share capital of the Company which is currently 60,239,150 Ordinary Shares.

 

Genus also announces that of 46,927 Ordinary Shares that vested today in favour of Ian Biggs, Head of Global Product & Business Strategy, under the Plan, 46,927 Ordinary Shares were today sold on behalf of Ian Biggs at a price of 1,000 pence per Ordinary Share.

 

Ian Biggs' direct shareholding in the Company stands at 3,375 Ordinary Shares which represents 0.01% of the issued share capital of the Company. In addition, he remains the beneficial owner of 78,415 conditional nil-cost options under the Plan.

 

Of 41,061 Ordinary Shares that vested today in favour of Thomas Philip Acton, Chief Operating Officer of Europe & The Far East, under the Plan, 31,061 Ordinary Shares were today sold on behalf of Thomas Philip Acton at a price of 1,000 pence per Ordinary Share.

 

Thomas Philip Acton's direct shareholding in the Company now stands at 31,104 Ordinary Shares which represents 0.06% of the issued share capital of the Company. In addition, he remains the beneficial owner of 78,415 conditional nil-cost options under the Plan.

 

Of 28,156 Ordinary Shares that vested today in favour of Ian Farrelly, Group Company Secretary & General Counsel, under the Plan, 28,156 Ordinary Shares were today sold on behalf of Ian Farrelly at a price of 1,000 pence per Ordinary Share.

 

Ian Farrelly has no direct shareholding in the Company. He remains the beneficial owner of 61,462 conditional nil-cost options under the Plan.

 

Genus further announces that of 1,619 Ordinary Shares which vested today in favour of Bill Christianson, Chief Operating Officer, The Americas, under the Genus 2004 Executive Share Option Plan (the "ESOP"), 1,619 Ordinary Shares were today sold on behalf of Bill Christianson at a price of 1,000 pence per Ordinary Share.

 

Bill Christianson has no direct shareholding in the Company and is the beneficial owner of 56,953 conditional nil-cost options and 18,970 market value share options.

 

Of 6,673 Ordinary Shares which vested today in favour of David Crosby, Group Financial Controller, under the ESOP, 6,673 Ordinary Shares were today sold on behalf of David Crosby at a price of 1,000 pence per Ordinary Share.

 

David Crosby has no direct shareholding in the Company and is the beneficial owner of 53,843 conditional nil-cost options.

 

 

For further information please contact:

 

Cara Crichton

Assistant Company Secretary

Genus plc

 

Tel: 01256 345996

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
RDSURRSRANAKUAR
Date   Source Headline
13th Mar 20077:01 amRNSInterim Results
5th Mar 20074:43 pmRNSBlocklisting Interim Review
5th Mar 20077:04 amRNSAdoption of IFRS
2nd Feb 20072:00 pmRNSBlocklisting Interim Review
9th Jan 20077:00 amRNSPre Close Trading Update
15th Dec 20061:19 pmRNSTotal Voting Rights
16th Nov 20063:15 pmRNSResult of AGM
16th Nov 20067:01 amRNSAGM Trading Update
9th Nov 200611:08 amRNSNotification of Interest
11th Oct 20064:05 pmRNSDirector Shareholding
11th Oct 20067:00 amRNSDisposal
20th Sep 20067:02 amRNSPreliminary Results
6th Sep 20067:00 amRNSBlocklisting Interim Review
17th Aug 20063:49 pmRNSNotice of Results
16th Aug 20061:15 pmRNSHolding(s) in Company
21st Jul 20062:07 pmRNSAdditional Listing
23rd Jun 20062:26 pmRNSDirectors' Share Awards
14th Jun 20069:02 amRNSDisposal
7th Jun 20067:01 amRNSInterim Results
15th May 20061:40 pmRNSNotice of Results
5th Apr 20067:00 amRNSPre-Close Trading Update
7th Mar 200612:17 pmRNSDirector/PDMR Shareholding
28th Feb 20064:06 pmRNSAdditional Listing
24th Feb 20067:01 amRNSDisposal
31st Jan 20065:06 pmRNSAdditional Listing
10th Jan 20063:12 pmRNSAdditional Listing
15th Dec 20056:34 pmRNSHolding(s) in Company
15th Dec 20056:20 pmRNSHolding(s) in Company
7th Dec 20057:01 amRNSDirectors' Share Awards
2nd Dec 20058:38 amRNSOffer Update
29th Nov 20057:02 amRNSInterim Results
25th Nov 200512:54 pmRNSOffer Update
22nd Nov 20057:02 amRNSOffer Update
18th Nov 20059:16 amRNSSchedule 1 - Genus PLC
14th Nov 200512:51 pmRNSOffer Update
11th Nov 20054:15 pmRNSRule 8.1- (Sygen)
8th Nov 20052:05 pmRNSOffer Update
4th Nov 20052:40 pmRNSRule 8.1- (Sygen)
3rd Nov 200512:48 pmRNSOffer Update
3rd Nov 20057:00 amRNSNotice of Interim Results
2nd Nov 20055:20 pmRNSRule 8.1- (Sygen)
2nd Nov 200510:19 amRNSOffer Update
1st Nov 20056:05 pmRNSRule 8.1- (Sygen)
1st Nov 200512:59 pmRNSOffer Document Posted
28th Oct 20055:48 pmRNSDisposal
28th Oct 20057:01 amRNSOffer for Sygen Int. plc
10th Oct 20057:00 amRNSPre-Close Trading Update
18th Aug 20054:13 pmRNSResult of AGM
18th Aug 20057:00 amRNSAGM Statement
19th Jul 200511:36 amRNSIssue of Equity

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.